Cosmetic cross-reference Noindex: medium evidence

Edetate Dipotassium Anhydrous

CAS 2001-94-7

Edetate Dipotassium Anhydrous (CAS 2001-94-7) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
0
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Edetate Dipotassium Anhydrous
CAS Number
2001-94-7
UNII
3W5S57M958
InChIKey
QLBHNVFOQLIYTH-UHFFFAOYSA-L
ChEMBL ID
CHEMBL2219741
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Edetate Dipotassium Anhydrous used for in pharmaceutical contexts?

Edetate Dipotassium Anhydrous (CAS 2001-94-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Edetate Dipotassium Anhydrous?

No adverse-event association or SIDER side-effect rows are rendered for Edetate Dipotassium Anhydrous in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Edetate Dipotassium Anhydrous also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Dipotassium EDTA with EU status "permitted".

What clinical phase is Edetate Dipotassium Anhydrous in?

No phase 1-4 clinical development badge is rendered for Edetate Dipotassium Anhydrous because the matched compound identifier rows do not contain a max-phase value.